CYT997 is an orally available vascular argeting and cytotoxic agent that has proven effective in animal models of a wide range of tumour types including breast, prostate and colon, as well as some leukemias.
Investigated for use/treatment in solid tumors.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.